Philadelphia Chromosome-positive Leukemias

• CLINICAL_TRIALS trial_result · 2018-01-05
  Clinical Trial Update: A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib [Phase 2]

  Phase II pediatric study evaluating dasatinib for newly diagnosed chronic phase chronic myeloid leukemia or Philadelphia chromosome-positive…

• EMA safety_alert · 2014-10-10
  PRAC recommends further measures to minimise risk of blood vessel blockage with Iclusig

  The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) recommends additional measures to reduce the risk of blood vessel blockage with…

• CLINICAL_TRIALS withdrawal · 2013-03-15
  Clinical Trial Update: Compassionate Use Ponatinib

  This clinical trial update indicates that the compassionate-use program for ponatinib is no longer available.